+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stents Market - Global Forecast 2026-2032- Product Image
Stents Market - Global Forecast 2026-2032- Product Image
Sale

Stents Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082308
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Stents Market is projected to reach USD 16.11 Billion in 2026. It is expected to continue growing at a CAGR of 7.75%, reaching USD 25.33 Billion by 2032.

The stents market is anchored by the global burden of cardiovascular, peripheral vascular, neurovascular, and urological disease. The World Health Organization identifies cardiovascular diseases as the leading cause of death worldwide, responsible for an estimated 17.9 million deaths annually, which sustains procedural demand for percutaneous coronary intervention, peripheral artery intervention, and other minimally invasive therapies.

Drug-eluting stents, covered stents, bare-metal stents, bioresorbable scaffolds, carotid stents, ureteral stents, and intracranial stent systems continue to evolve around three measurable priorities: improving vessel patency, reducing restenosis and thrombosis risk, and enabling faster patient recovery. Industry momentum is shaped by clinical guideline adoption, hospital catheterization laboratory capacity, reimbursement policy, material science, and stronger evidence requirements from regulators such as the U.S. FDA and European authorities under the Medical Device Regulation.

Transformative Shifts in the Stents Landscape

The stents landscape is shifting from device-centric competition toward evidence-led, procedure-integrated care. New-generation drug-eluting stents have largely displaced bare-metal stents in coronary intervention because randomized evidence and clinical guidelines support lower repeat revascularization rates in many patient groups. At the same time, peripheral vascular stents and covered stents are expanding with the rising diagnosis of peripheral artery disease, particularly among aging and diabetic populations.

Transformative change is also coming from imaging-guided intervention, radial access, complex lesion treatment, and device miniaturization. Intravascular ultrasound, optical coherence tomography, and fractional flow reserve are improving lesion assessment and stent optimization. Manufacturers are increasingly differentiating through polymer durability, drug-release profiles, alloy design, deliverability, radiopacity, and compatibility with complex anatomies rather than through platform claims alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the stents value chain from diagnosis to post-market surveillance. In clinical settings, AI-enabled image analysis can support coronary calcium assessment, lesion quantification, vessel sizing, and automated interpretation of angiography, CT angiography, intravascular ultrasound, and optical coherence tomography datasets. These capabilities are relevant because inappropriate sizing or incomplete lesion assessment can increase the risk of restenosis, malapposition, or repeat intervention.

AI is also strengthening manufacturing quality control, supply planning, inventory allocation, and adverse-event signal detection across regulated medical device ecosystems. However, adoption depends on validated algorithms, diverse training datasets, cybersecurity controls, explainability, and regulatory-grade evidence. Industry leaders that pair AI with prospective clinical validation and human-in-the-loop workflows are better positioned to improve procedural consistency without overstating autonomous decision-making.

Key Regional Insights for Stents

Asia-Pacific is a high-priority region for stents because of large patient pools, rising health insurance coverage, and expanding interventional cardiology capacity in China, India, Japan, South Korea, Australia, and Southeast Asia. The region is also influenced by the rapid increase in diabetes and hypertension, both recognized risk factors for coronary artery disease and peripheral artery disease. North America remains mature but innovation-intensive, supported by advanced catheterization laboratory infrastructure, FDA-cleared technologies, strong clinical trial activity, and high use of drug-eluting stents, covered stents, and peripheral vascular stents.

Latin America is advancing through public-private hospital investment and broader access to percutaneous coronary intervention in Brazil, Mexico, and major urban centers, though affordability, public reimbursement, and specialist distribution continue to shape access. Europe benefits from guideline-driven care, centralized procurement, established interventional cardiology networks, and MDR-led safety and post-market surveillance expectations. The Middle East is investing in tertiary cardiac centers, digital hospitals, and medical tourism hubs, while Africa presents long-term opportunity as cardiovascular diagnosis improves; however, access to interventional procedures remains uneven due to infrastructure gaps, specialist availability, and payer limitations.

Key Group Insights Across Major Economic Blocs

ASEAN demand is influenced by rising diabetes, hypertension, urbanization, and the buildout of cardiac care networks across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is characterized by high cardiovascular risk factors, significant public healthcare spending, and a preference for internationally validated technologies in leading hospitals. The European Union remains a benchmark for safety, traceability, clinical evidence, and post-market surveillance under the Medical Device Regulation, making regulatory readiness essential for coronary, peripheral, carotid, and ureteral stent suppliers.

BRICS countries combine large disease burdens with heterogeneous reimbursement, procurement, and domestic manufacturing systems, creating demand for both premium and cost-effective stent platforms. G7 markets drive clinical evidence generation, next-generation drug-eluting stent adoption, imaging-guided PCI, and long-term outcomes research. NATO countries are increasingly relevant to supply-chain resilience because medical device availability is viewed through healthcare security, logistics redundancy, sterile manufacturing continuity, and critical infrastructure preparedness.

Key Country Insights for Stents Demand

The United States leads in advanced coronary intervention, clinical trial activity, and FDA-regulated device innovation, while Canada emphasizes evidence-based reimbursement and equitable provincial access. Mexico and Brazil are important Latin American markets where urban cardiac centers support PCI adoption, although public-sector purchasing, reimbursement timing, and affordability shape the product mix. In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from mature cardiology networks, national guideline alignment, and broad access to drug-eluting stents, with Germany maintaining a strong role in interventional procedure volume and medical technology adoption.

Russia presents demand for cardiovascular intervention but faces procurement and supply-chain complexity. China is scaling domestic stent manufacturing and expanding PCI access through hospital network development, while India is driven by a high coronary disease burden, price-sensitive procurement, and increasing access to interventional cardiology outside major metropolitan centers. Japan is distinguished by advanced imaging use, strict quality expectations, and strong procedural standardization. Australia and South Korea combine modern hospital infrastructure, reimbursement discipline, and high adoption of clinically validated stent technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation across real-world populations, including patients with diabetes, chronic kidney disease, calcified lesions, small vessels, bifurcation disease, and complex peripheral artery disease. Differentiation should focus on measurable outcomes such as target lesion failure, stent thrombosis, restenosis, deliverability, procedural efficiency, radial access compatibility, and long-term safety.

Organizations should also strengthen AI-enabled imaging partnerships, invest in resilient regional supply chains, and design market access strategies by reimbursement tier. In emerging markets, value-engineered platforms, physician training, clinical education, and financing partnerships can accelerate responsible adoption. In mature markets, clinical evidence, interoperability with imaging systems, post-market data transparency, and compliance with evolving medical device regulations will be decisive.

Research Methodology

This executive summary is developed from a structured secondary research methodology using verified public sources, including WHO disease burden data, regulatory guidance from the U.S. FDA and European medical device authorities, clinical guideline positions from major cardiology societies, peer-reviewed evidence on drug-eluting stents and PCI, and publicly available healthcare infrastructure indicators.

The analysis applies cross-validation across epidemiology, reimbursement, regulatory, clinical, and technology adoption signals. Interpretations avoid unsupported projections and emphasize observable drivers: disease prevalence, procedure access, device regulation, procurement behavior, clinical outcomes, physician adoption, and innovation readiness.

Conclusion

The stents market remains clinically essential as cardiovascular and vascular disease continue to pressure healthcare systems worldwide. Demand is being reshaped by drug-eluting platforms, covered stents, advanced imaging, AI-assisted decision support, and stronger regulatory expectations for safety and long-term evidence.

Sustainable growth will favor organizations that combine proven device performance with data transparency, physician training, supply reliability, and region-specific market access strategies. The next phase of competition will be defined not only by better stent design, but also by stronger integration into evidence-based, minimally invasive care pathways.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Stents Market, by Product Type
7.1. Introduction
7.2. Coronary Stents
7.3. Gastrointestinal Stents
7.4. Neurovascular Stents
7.4.1. Extracranial Carotid Artery Stents
7.4.2. Intracranial Stents
7.5. Peripheral Stents
7.5.1. Carotid Artery Stents
7.5.2. Femoral Artery Stents
7.5.3. Iliac Artery Stents
7.5.4. Renal Artery Stents
7.6. Urological Stents
7.6.1. Prostatic Stents
7.6.2. Ureteral Stents
8. Stents Market, by Material
8.1. Introduction
8.2. Metallic Stents
8.2.1. Cobalt Chromium
8.2.2. Nitinol
8.2.3. Platinum Chromium
8.2.4. Stainless Steel
8.3. Polymeric Stents
8.3.1. Biodegradable Polymers
8.3.2. Non-biodegradable Polymers
9. Stents Market, by Mode of Delivery
9.1. Introduction
9.2. Balloon-Expandable Stents
9.3. Self-Expanding Stents
10. Stents Market, by Application
10.1. Introduction
10.2. Cardiovascular Diseases
10.3. Gastrointestinal Obstructions
10.4. Neurovascular Conditions
10.5. Oncology-Related Applications
10.6. Peripheral Artery Disease (PAD)
10.7. Urological Disorders
11. Stents Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers (ASCs)
11.3. Cardiology Centers
11.4. Hospitals
11.5. Specialty Clinics
12. Stents Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Stents Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Stents Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. United Kingdom
14.6. India
14.7. Japan
14.8. South Korea
14.9. Canada
14.10. Australia
14.11. France
14.12. Italy
14.13. Brazil
14.14. Russia
14.15. Mexico
14.16. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. B. Braun AG
16.3. Becton, Dickinson and Company
16.4. Biosensors International Group, Ltd.
16.5. Boston Scientific Corporation
16.6. Concept Medical
16.7. Cook Medical LLC
16.8. Cordis Corporation
16.9. Elixir Medical Corporation
16.10. ELLA - CS, s.r.o.
16.11. Endologix LLC
16.12. Glaukos Corporation
16.13. Hexacath
16.14. InspireMD, Inc.
16.15. Integer Holdings Corporation
16.16. Lepu Medical Technology Co., Ltd
16.17. Medinol Ltd.
16.18. Medtronic plc
16.19. Meril Life Sciences Pvt. Ltd
16.20. MicroPort Scientific Corporation
16.21. OrbusNeich Medical Group Holdings Limited
16.22. Relisys Medical Devices Limited
16.23. Sahajanand Medical Technologies Pvt. Ltd
16.24. Terumo Corporation
16.25. Translumina Therapeutics
16.26. W. L. Gore & Associates, Inc.
17. Key Experts
List of Figures
FIGURE 1. Global Stents Market, Years Considered for the Study
FIGURE 2. Global Stents Market, Research Design
FIGURE 3. Global Stents Market, Research Framework
FIGURE 4. Global Stents Market, Data Triangulation
FIGURE 5. Global Stents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Stents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Stents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Stents Market Size, by Material, 2025 vs 2032 (%)
FIGURE 9. Global Stents Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Stents Market Size, by Mode of Delivery, 2025 vs 2032 (%)
FIGURE 11. Global Stents Market Size, by Mode of Delivery, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Stents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Stents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Stents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Stents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Stents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Stents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Stents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Stents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Stents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Stents Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Stents Market Segmentation & Coverage
TABLE 2. Global Stents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Coronary Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Gastrointestinal Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Gastrointestinal Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Gastrointestinal Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Neurovascular Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Neurovascular Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Neurovascular Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Extracranial Carotid Artery Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Extracranial Carotid Artery Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Extracranial Carotid Artery Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Intracranial Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Intracranial Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Intracranial Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Peripheral Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Peripheral Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Peripheral Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Carotid Artery Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Carotid Artery Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Carotid Artery Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Femoral Artery Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Femoral Artery Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Femoral Artery Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Iliac Artery Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Iliac Artery Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Iliac Artery Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Renal Artery Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Renal Artery Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Renal Artery Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Urological Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Urological Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Urological Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Prostatic Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Prostatic Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Prostatic Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Ureteral Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Ureteral Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Ureteral Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 44. Global Metallic Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Metallic Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Metallic Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Cobalt Chromium Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Cobalt Chromium Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Cobalt Chromium Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Nitinol Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Nitinol Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Nitinol Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Platinum Chromium Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Platinum Chromium Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Platinum Chromium Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Stainless Steel Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Stainless Steel Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Stainless Steel Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Polymeric Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Polymeric Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Polymeric Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Biodegradable Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Biodegradable Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Biodegradable Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Non-biodegradable Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Non-biodegradable Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Non-biodegradable Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 69. Global Balloon-Expandable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Balloon-Expandable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Balloon-Expandable Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Self-Expanding Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Self-Expanding Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Self-Expanding Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Global Cardiovascular Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Cardiovascular Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Cardiovascular Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Gastrointestinal Obstructions Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Gastrointestinal Obstructions Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Gastrointestinal Obstructions Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Neurovascular Conditions Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Neurovascular Conditions Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Neurovascular Conditions Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Oncology-Related Applications Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Oncology-Related Applications Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Oncology-Related Applications Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Peripheral Artery Disease (PAD) Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Peripheral Artery Disease (PAD) Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Peripheral Artery Disease (PAD) Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Urological Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Urological Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Urological Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Global Ambulatory Surgical Centers (ASCs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Ambulatory Surgical Centers (ASCs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Ambulatory Surgical Centers (ASCs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Cardiology Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Cardiology Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Cardiology Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. North America Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. North America Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. North America Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 122. North America Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 123. North America Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 124. North America Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 125. North America Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 126. North America Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 127. North America Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 128. North America Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. North America Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. Latin America Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Latin America Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. Latin America Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 133. Latin America Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 134. Latin America Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 135. Latin America Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 136. Latin America Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 137. Latin America Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 138. Latin America Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 139. Latin America Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. Latin America Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Europe Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Europe Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. Europe Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 144. Europe Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 145. Europe Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 146. Europe Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 147. Europe Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 148. Europe Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 149. Europe Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 150. Europe Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Europe Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Middle East Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Middle East Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. Middle East Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 155. Middle East Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 156. Middle East Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 157. Middle East Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 158. Middle East Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 159. Middle East Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 160. Middle East Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 161. Middle East Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Middle East Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Africa Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Africa Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. Africa Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 166. Africa Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 167. Africa Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 168. Africa Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 169. Africa Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 170. Africa Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 171. Africa Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 172. Africa Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. Africa Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Global Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. ASEAN Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. ASEAN Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. ASEAN Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 178. ASEAN Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 179. ASEAN Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 180. ASEAN Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 181. ASEAN Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 182. ASEAN Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 183. ASEAN Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 184. ASEAN Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. ASEAN Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. GCC Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. GCC Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. GCC Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 189. GCC Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 190. GCC Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 191. GCC Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 192. GCC Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 193. GCC Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 194. GCC Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 195. GCC Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. GCC Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. European Union Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. European Union Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. European Union Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 200. European Union Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 201. European Union Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 202. European Union Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 203. European Union Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 204. European Union Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 205. European Union Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 206. European Union Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. European Union Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. BRICS Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. BRICS Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. BRICS Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 211. BRICS Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 212. BRICS Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 213. BRICS Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 214. BRICS Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 215. BRICS Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 216. BRICS Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 217. BRICS Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. BRICS Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. G7 Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. G7 Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. G7 Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 222. G7 Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 223. G7 Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 224. G7 Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 225. G7 Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 226. G7 Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 227. G7 Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 228. G7 Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. G7 Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. NATO Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 231. NATO Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. NATO Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 233. NATO Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 234. NATO Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 235. NATO Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 236. NATO Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 237. NATO Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 238. NATO Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 239. NATO Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. NATO Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Global Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 242. United States Stents Market Size, 2017-2032 (USD Million)
TABLE 243. United States Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. United States Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 245. United States Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 246. United States Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 247. United States Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 248. United States Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 249. United States Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 250. United States Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 251. United States Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. United States Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. China Stents Market Size, 2017-2032 (USD Million)
TABLE 254. China Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. China Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 256. China Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 257. China Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 258. China Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 259. China Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 260. China Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 261. China Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 262. China Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. China Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. Germany Stents Market Size, 2017-2032 (USD Million)
TABLE 265. Germany Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. Germany Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 267. Germany Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 268. Germany Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 269. Germany Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 270. Germany Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 271. Germany Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 272. Germany Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 273. Germany Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. Germany Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. United Kingdom Stents Market Size, 2017-2032 (USD Million)
TABLE 276. United Kingdom Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. United Kingdom Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 278. United Kingdom Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 279. United Kingdom Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 280. United Kingdom Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 281. United Kingdom Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 282. United Kingdom Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 283. United Kingdom Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 284. United Kingdom Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. United Kingdom Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. India Stents Market Size, 2017-2032 (USD Million)
TABLE 287. India Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. India Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 289. India Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 290. India Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 291. India Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 292. India Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 293. India Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 294. India Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 295. India Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 296. India Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Japan Stents Market Size, 2017-2032 (USD Million)
TABLE 298. Japan Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. Japan Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 300. Japan Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 301. Japan Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 302. Japan Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 303. Japan Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 304. Japan Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 305. Japan Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 306. Japan Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. Japan Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. South Korea Stents Market Size, 2017-2032 (USD Million)
TABLE 309. South Korea Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 310. South Korea Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 311. South Korea Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 312. South Korea Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 313. South Korea Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 314. South Korea Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 315. South Korea Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 316. South Korea Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 317. South Korea Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 318. South Korea Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. Canada Stents Market Size, 2017-2032 (USD Million)
TABLE 320. Canada Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 321. Canada Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 322. Canada Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 323. Canada Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 324. Canada Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 325. Canada Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 326. Canada Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 327. Canada Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 328. Canada Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 329. Canada Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 330. Australia Stents Market Size, 2017-2032 (USD Million)
TABLE 331. Australia Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 332. Australia Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 333. Australia Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 334. Australia Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 335. Australia Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 336. Australia Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 337. Australia Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 338. Australia Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 339. Australia Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 340. Australia Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 341. France Stents Market Size, 2017-2032 (USD Million)
TABLE 342. France Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 343. France Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 344. France Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 345. France Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 346. France Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 347. France Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 348. France Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 349. France Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 350. France Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 351. France Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 352. Italy Stents Market Size, 2017-2032 (USD Million)
TABLE 353. Italy Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 354. Italy Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 355. Italy Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 356. Italy Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 357. Italy Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 358. Italy Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 359. Italy Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 360. Italy Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 361. Italy Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 362. Italy Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 363. Brazil Stents Market Size, 2017-2032 (USD Million)
TABLE 364. Brazil Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 365. Brazil Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 366. Brazil Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 367. Brazil Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 368. Brazil Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 369. Brazil Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 370. Brazil Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 371. Brazil Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 372. Brazil Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 373. Brazil Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 374. Russia Stents Market Size, 2017-2032 (USD Million)
TABLE 375. Russia Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 376. Russia Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 377. Russia Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 378. Russia Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 379. Russia Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 380. Russia Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 381. Russia Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 382. Russia Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 383. Russia Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 384. Russia Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 385. Mexico Stents Market Size, 2017-2032 (USD Million)
TABLE 386. Mexico Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 387. Mexico Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 388. Mexico Stents Market Size, by Peripheral Stents, 2017-2032 (USD Million)
TABLE 389. Mexico Stents Market Size, by Urological Stents, 2017-2032 (USD Million)
TABLE 390. Mexico Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 391. Mexico Stents Market Size, by Metallic Stents, 2017-2032 (USD Million)
TABLE 392. Mexico Stents Market Size, by Polymeric Stents, 2017-2032 (USD Million)
TABLE 393. Mexico Stents Market Size, by Mode of Delivery, 2017-2032 (USD Million)
TABLE 394. Mexico Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 395. Mexico Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 396. Spain Stents Market Size, 2017-2032 (USD Million)
TABLE 397. Spain Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 398. Spain Stents Market Size, by Neurovascular Stents, 2017-2032 (USD Million)
TABLE 399. Spain Sten

Companies Mentioned

  • Abbott Laboratories
  • B. Braun AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Boston Scientific Corporation
  • Concept Medical
  • Cook Medical LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • ELLA – CS, s.r.o.
  • Endologix LLC
  • Glaukos Corporation
  • Hexacath
  • InspireMD, Inc.
  • Integer Holdings Corporation
  • Lepu Medical Technology Co., Ltd
  • Medinol Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Group Holdings Limited
  • Relisys Medical Devices Limited
  • Sahajanand Medical Technologies Pvt. Ltd
  • Terumo Corporation
  • Translumina Therapeutics
  • W. L. Gore & Associates, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.11 Billion
Forecasted Market Value ( USD ) by 2032 $ 25.33 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Gastric Bypass Stent System Market Global Report 2026 - Product Image

Gastric Bypass Stent System Market Global Report 2026

  • Report
  • 250 Pages
  • Global
From
Vascular Stent Market - Global Forecast 2026-2032 - Product Image

Vascular Stent Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Bioabsorbable Stents Market - Global Forecast 2026-2032 - Product Image

Bioabsorbable Stents Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Stents - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Stents - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 112 Pages
  • Global
From
Intravascular Stents - Global Strategic Business Report - Product Image

Intravascular Stents - Global Strategic Business Report

  • Report
  • 462 Pages
  • Global
From

About the Stents Market

The Stents market is a segment of the medical device industry that focuses on the production of stents. Stents are small, tube-shaped devices that are inserted into the body to treat a variety of medical conditions. They are used to open blocked arteries, treat aneurysms, and provide support to weakened vessels. Stents are typically made of metal, plastic, or a combination of both. The Stents market is highly competitive, with a number of major players. Some of the leading companies in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, and Johnson & Johnson. These companies are constantly innovating and developing new products to meet the needs of their customers. In addition to the major players, there are also a number of smaller companies that specialize in the production of stents. These companies often focus on niche markets, such as pediatric stents or stents for specific medical conditions. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.